THISX Mutual Fund

NAV$89.95

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
0.67%
Dividend Yield (Current)
11.42%
Holdings
281
Inception Date
Mar 23, 2016
Fund Family
T.Rowe Price
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.32%
1 Year+30.37%
3 Year+7.76%
5 Year+2.87%
10 Year+10.45%

Asset Allocation

Stocks: 99.14%
Bonds: 0.14%
Other: 0.72%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.38%
ISRGINTUITIVE SURG4.48%
TMOThermo Fisher4.27%
ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs3.88%
SYKStryker Corp 3.375 11/253.52%
Top 10 Concentration: 42.68%Report Date: Dec 31, 2025
Download all 281 holdings for THISX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
11.42%
Frequency
Annually
Latest Distribution
$7.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how THISX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

THISX Mutual Fund Overview

THISX Mutual Fund (T. Rowe Price Health Sciences Fund Class I) is managed by T.Rowe Price. THISX expense ratio is 0.67%, holding 281 positions across sectors including Health Care, Unknown, Other. Inception date: 2016-03-23.

THISX performance shows a YTD return of 7.32%. The 1-year return is 30.37% and the 5-year return is 2.87%. THISX dividend yield stands at 11.42%, paid annually.

THISX top holdings include Eli Lilly & Co (12.4%), INTUITIVE SURG (4.5%), Thermo Fisher (4.3%), Argenx Se Spon Adr Each Rep 1 Ord Shs (3.9%), Stryker Corp 3.375 11/25 (3.5%). View all THISX holdings, sector breakdown, or dividend history.

THISX can be compared against other funds using the overlap calculator or side-by-side comparison tool. THISX alternatives are available via the screener, along with tax-loss harvesting opportunities.